OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 02, 2020
The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.
November 06, 2019
The company will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media.
October 24, 2019
Through the agreement, Foamix will have access to $20 million of financing to fund the commercial launches of the topical treatments.
August 03, 2018
AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material.
November 09, 2017
The company has officially opened a local brand office in South Korean to support its existing business in the region.
October 23, 2017
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
July 31, 2017
Stainless-steel particulates were found in one lot of 0.9% Sodium Chloride Injection, USP 1000 mL, prompting the recall to the hospital/user level.
May 05, 2017
Operated by BioOutsource, Sartorius’ subsidiary, the Glasgow, UK-based service center will offer physicochemical properties and structural attributes testing and allow clients to perform structural and functional analyses in parallel.
May 01, 2017
The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.
December 30, 2014
Hospira issued a voluntary worldwide recall due to confirmed subpotency and elevated impurity levels.